Lindahl acts as an advisor when Amferia enters into an agreement with Orkla Wound Care
Through the collaboration with Orkla Wound Care, Amferia’s innovative technology will reach the veterinary market through Orkla’s leading brand Snögg Animal Care.
Amferia’s technology is based on an antimicrobial gel that inhibits bacterial growth and can help prevent infections – a priority area in the European veterinary market, particularly in view of the growing risk of antibiotic-resistant infections. Amferia’s technology and materials have been developed through many years’ research in collaboration with Chalmers University of Technology.
Read more about Amferia and the agreement at amferia.com.
Patrik Rindstål was the Lindahl partner in charge.
Do you want to know more? Contact:
Patrik Rindstål
Managing Partner Uppsala | AdvokatCarousel items
-
News articles
6/2/2025
Lindahl Recognized in IP Stars 2025
Lindahl has recently been recognized in the 2025 edition of IP Stars, where the firm’s intellectual property experts received several awards. The ranking highlights Lindahl’s capabilities in areas such as trademark work, copyright, and patents, wi...
-
Cases and transactions
6/2/2025
Lindahl advises Salix Järn, Bygg & Agri AB on the acquisition of Hans Eggestrand AB
Lindahl has acted as legal advisor to Salix Järn, Bygg & Agri AB, a company within the Nordic trading group Salix Group, in the acquisition of Hans Eggestrand AB.
-
Portraits
6/2/2025
Meet our Office Manager Olivia: a key person at Lindahl in Malmö
Behind every welcoming office environment, every successful gathering and event at Lindahl’s offices, there are important people pulling the strings. In Malmö, one of these is Office Manager Olivia Nelderup.
-
Knowledge
5/30/2025
Copyright vs AI in the Court of Justice of the EU
Of course, it was only a matter of time before AI, artificial intelligence, would end up in a formal dispute with copyright and be scrutinised by the European Court of Justice. Admittedly, this is not the first time that new technologies have inte...
-
Read more news and insights?
